<DOC>
	<DOCNO>NCT00018603</DOCNO>
	<brief_summary>This double-blind , placebo-controlled , randomized study last 8 week . Purpose study two-fold : first , use pharmacological agent treat symptom PTSD , second , explore neurobiological mechanism action guanfacine .</brief_summary>
	<brief_title>Guanfacine Treatment Post Traumatic Stress Disorder ( PTSD )</brief_title>
	<detailed_description>Subject population comprise 100 person PTSD . 50 patient receive guanfacine 50 patient receive placebo . Guanfacine prescribe 1 mg/day may increase 2 mg/day . Samples plasma MHPG collect weekly . Clinical rating PTSD anxiety depression , well vital sign , assess weekly . Repeated measure analysis variance ass significance main effect drug , time , drug time .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Males female , age 1865 Diagnosis PTSD combat civilian trauma No major medical problem diabetes , cardiovascular disease Taking psychiatric medication , take one SSRI antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>PTSD</keyword>
</DOC>